Literature DB >> 25652606

Early infectious acute respiratory distress syndrome is characterized by activation and proliferation of alveolar T-cells.

K Risso1, G Kumar, M Ticchioni, C Sanfiorenzo, J Dellamonica, F Guillouet-de Salvador, G Bernardin, C-H Marquette, P-M Roger.   

Abstract

Acute respiratory distress syndrome (ARDS) in humans is characterized by the infiltration of polymorphonuclears in the alveolar spaces. However, the role of T-cells in ARDS is unknown. Our aim was to characterize the T-cell phenotype in bronchoalveolar lavage (BAL) during the early phase of acute lung infection(ALI)/ARDS-infected patients in comparison to a control group (CG). BAL lymphocyte phenotypes of two ALI, 16 ARDS, and eight CG were examined by flow cytometry. ALI/ARDS showed a significant increase in CD4 and CD8 T-cell activation as compared to CG. Moreover, a significant level of proliferation was observed using the Ki67 marker in ARDS patients as compared to controls (median): 37 versus 6 % for CD4 T-cells (p = 0.022) and 34 versus 2 % for CD8 T-cells (p = 0.009). In contrast, the percentage of T-regulatory cells and apoptotic T-cells were similar in both groups. Among costimulatory molecules, we observed an overexpression of CTLA-4/CD152 on CD4 T-cells in ALI/ARDS as compared to CG: 30 versus 7 %, respectively (p = 0.063). In further characterizing T-cell subsets expressing high levels of CD152, we found the presence of IL-17 secreting CD4 T-cells in ALI/ARDS. In humans, ALI/ARDS due to infection is associated with a high level of T-cell activation and proliferation, along with the presence of Th17 cells, which are known to attract polymorphonuclears.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25652606     DOI: 10.1007/s10096-015-2333-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  32 in total

Review 1.  The two-signal model of T-cell activation after 30 years.

Authors:  Alain Bernard; Laurence Lamy And; Isabelle Alberti
Journal:  Transplantation       Date:  2002-01-15       Impact factor: 4.939

2.  Interleukin-dependent modulation of HLA-DR expression on CD4and CD8 activated T cells.

Authors:  Francisco J Salgado; Juan Lojo; Carmen M Fernández-Alonso; JuanE Viñuela; Oscar J Cordero; Montserrat Nogueira
Journal:  Immunol Cell Biol       Date:  2002-04       Impact factor: 5.126

Review 3.  Interleukin-17 and type 17 helper T cells.

Authors:  Pierre Miossec; Thomas Korn; Vijay K Kuchroo
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

Review 4.  Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?

Authors:  Ingrid Müller; Markus Munder; Pascale Kropf; Gertrud Maria Hänsch
Journal:  Trends Immunol       Date:  2009-09-21       Impact factor: 16.687

Review 5.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

6.  T cell pathways involving CTLA4 contribute to a model of acute lung injury.

Authors:  Takeshi Nakajima; Carlos Jose Suarez; Ko-Wei Lin; Kai Yu Jen; Jan E Schnitzer; Samir S Makani; Nathan Parker; David L Perkins; Patricia W Finn
Journal:  J Immunol       Date:  2010-04-12       Impact factor: 5.422

Review 7.  New insights into the immunology of chronic obstructive pulmonary disease.

Authors:  Guy G Brusselle; Guy F Joos; Ken R Bracke
Journal:  Lancet       Date:  2011-09-10       Impact factor: 79.321

8.  One-year outcomes in survivors of the acute respiratory distress syndrome.

Authors:  Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

9.  CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Erin E West; Matthew H Willett; Martin F Britos; Matthew R Pipeling; Roy G Brower; Rubin M Tuder; John F McDyer; Landon S King
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 10.  Acute lung injury review.

Authors:  Kenji Tsushima; Landon S King; Neil R Aggarwal; Antonio De Gorordo; Franco R D'Alessio; Keishi Kubo
Journal:  Intern Med       Date:  2009-05-01       Impact factor: 1.271

View more
  16 in total

1.  Innate Lymphoid Cells and Acute Respiratory Distress Syndrome.

Authors:  Kong Chen; Jay K Kolls
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

2.  Fennel main constituent, trans‑anethole treatment against LPS‑induced acute lung injury by regulation of Th17/Treg function.

Authors:  Sichao Zhang; Xi Chen; Ichinkhorloo Devshilt; Qi Yun; Cong Huang; Lijun An; Sosorburam Dorjbat; Xin He
Journal:  Mol Med Rep       Date:  2018-06-07       Impact factor: 2.952

3.  [Role of interleukin-17 in alveolar fluid clearance in mice with acute lung injury].

Authors:  Yan Zhao; Li Cheng; Zhi-Xin Song; Xin-Yu Deng; Jing He; Wang Deng; Dao-Xin Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

4.  Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia.

Authors:  Daisuke Yoshioka; Chiaki Kajiwara; Yoshikazu Ishii; Kenji Umeki; Kazufumi Hiramatsu; Jun-Ichi Kadota; Kazuhiro Tateda
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Therapeutic blockade of CD54 attenuates pulmonary barrier damage in T cell-induced acute lung injury.

Authors:  Julia Svedova; Antoine Ménoret; Payal Mittal; Joseph M Ryan; James A Buturla; Anthony T Vella
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-04       Impact factor: 5.464

6.  Innate-like function of memory Th17 cells for enhancing endotoxin-induced acute lung inflammation through IL-22.

Authors:  Ryota Sakaguchi; Shunsuke Chikuma; Takashi Shichita; Rimpei Morita; Takashi Sekiya; Wenjun Ouyang; Tomomi Ueda; Hiroyuki Seki; Hiroshi Morisaki; Akihiko Yoshimura
Journal:  Int Immunol       Date:  2015-12-08       Impact factor: 4.823

7.  The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the "cytokine storm" in COVID-19 patients: a hypothesis.

Authors:  Gregory Thomas; Elizabeth Frederick; Melissa Hausburg; Laura Goldberg; Marshall Hoke; Michael Roshon; Charles Mains; David Bar-Or
Journal:  Patient Saf Surg       Date:  2020-05-13

8.  Initiation of LPS-induced pulmonary dysfunction and its recovery occur independent of T cells.

Authors:  Eva Verjans; Stephanie Kanzler; Kim Ohl; Annette D Rieg; Nadine Ruske; Angela Schippers; Norbert Wagner; Klaus Tenbrock; Stefan Uhlig; Christian Martin
Journal:  BMC Pulm Med       Date:  2018-11-22       Impact factor: 3.317

9.  Rapamycin attenuates acute lung injury induced by LPS through inhibition of Th17 cell proliferation in mice.

Authors:  Zhao Yan; Zhang Xiaoyu; Song Zhixin; Qi Di; Deng Xinyu; Xia Jing; He Jing; Deng Wang; Zhong Xi; Zhang Chunrong; Wang Daoxin
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

10.  Role of IL-17 in LPS-induced acute lung injury: an in vivo study.

Authors:  Qi Ding; Gao-Qin Liu; Yuan-Yuan Zeng; Jian-Jie Zhu; Ze-Yi Liu; Xueguang Zhang; Jian-An Huang
Journal:  Oncotarget       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.